Jo Milner
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
- Oncology 33
- Cancer-related Molecular Pathways 32
-
- Sirtuins and Resveratrol in Medicine 10
- Co-authors
- Ming Jiang (7 shared papers)Elizabeth Medcalf (1 shared paper)Jack R. Ford (4 shared papers)Andrei L. Okorokov (8 shared papers)Carlos P. Rubbi (8 shared papers)Simon J. Allison (8 shared papers)John R. P. Knight (4 shared papers)Shafiq Uddin Ahmed (4 shared papers)
- Journals
- Oncogene (11 papers)Virology (5 papers)Nature (3 papers)The EMBO Journal (3 papers)Molecular and Cellular Biology (3 papers)
- Partner nations
- United KingdomUnited StatesNew Zealand
In The Last Decade
Jo Milner
60 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 101
- Geriatrics and Gerontology 395
- Oncology 1.3k
- Molecular Biology 1.3k
- Cancer Research 164
- Epidemiology 278
Countries citing papers authored by Jo Milner
This map shows the geographic impact of Jo Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Milner more than expected).
Fields of papers citing papers by Jo Milner
This network shows the impact of papers produced by Jo Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Milner. The network helps show where Jo Milner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jo Milner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 529 | |
| 2 | 2002 | 319 | |
| 3 | 2005 | 256 | |
| 4 | 2005 | 234 | |
| 5 | 1981 | 153 | |
| 6 | 1997 | 147 | |
| 7 | 2003 | 114 | |
| 8 | 2008 | 110 | |
| 9 | 1984 | 109 | |
| 10 | 2006 | 101 | |
| 11 | 2011 | 88 | |
| 12 | Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. | 1995 | 78 |
| 13 | 2000 | 70 | |
| 14 | 1995 | 59 | |
| 15 | 1998 | 59 | |
| 16 | 1991 | 58 | |
| 17 | 2002 | 58 | |
| 18 | 1997 | 56 | |
| 19 | 2000 | 54 | |
| 20 | 2009 | 53 |
About Jo Milner
Jo Milner is a scholar working on Oncology, Geriatrics and Gerontology, Molecular Biology, Hematology and Immunology, having authored 60 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (32 papers), Sirtuins and Resveratrol in Medicine (10 papers), RNA Interference and Gene Delivery (6 papers), Genomics and Chromatin Dynamics (4 papers), Signaling Pathways in Disease (3 papers), RNA and protein synthesis mechanisms (2 papers), T-cell and B-cell Immunology (2 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Geriatrics and Gerontology (395 citations), Oncology (1.3k citations), Molecular Biology (1.3k citations), Cancer Research (164 citations) and Epidemiology (278 citations). Jo Milner has collaborated with scholars based in United Kingdom, United States and New Zealand. Frequent co-authors include Ming Jiang, Elizabeth Medcalf, Jack R. Ford, Andrei L. Okorokov, Carlos P. Rubbi, Simon J. Allison, John R. P. Knight, Shafiq Uddin Ahmed, Lorna Jane Warnock and Nik Veldhoen. Their work appears in journals such as Oncogene, Virology, Nature, The EMBO Journal and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.